相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic features and application value of next generation sequencing in the diagnosis of synchronous multifocal lung adenocarcinoma
Xiaoyan Chen et al.
ONCOLOGY LETTERS (2020)
Transcriptional Characterization Of The Tumor Immune Microenvironment And Its Prognostic Value For Locally Advanced Lung Adenocarcinoma In A Chinese Population
Yuqiao Chen et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions
Weihua Li et al.
MOLECULAR ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Next-Generation Sequencing A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases
Snehal B. Patel et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Utility of Genomic Analysis in Differentiating Synchronous and Metachronous Lung Adenocarcinomas from Primary Adenocarcinomas with Intrapulmonary Metastasis
Jad Saab et al.
TRANSLATIONAL ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging
Frank Schneider et al.
MODERN PATHOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prognosis of synchronous and metachronous multiple primary lung cancers: Systematic review and meta-analysis
Long Jiang et al.
LUNG CANCER (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
Yago Pico de Coana et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Identification of Independent Primary Tumors and Intrapulmonary Metastases Using DNA Rearrangements in Non-Small-Cell Lung Cancer
Stephen J. Murphy et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases
Kanji Nagai et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Preferential apoptosis of CD56(dim) natural killer cell subset in patients with cancer
T Bauernhofer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
分享论文
